125 related articles for article (PubMed ID: 25131659)
1. MALDI imaging-based identification of prognostically relevant signals in bladder cancer using large-scale tissue microarrays.
Steurer S; Singer JM; Rink M; Chun F; Dahlem R; Simon R; Burandt E; Stahl P; Terracciano L; Schlomm T; Wagner W; Höppner W; Omidi M; Kraus O; Kwiatkowski M; Doh O; Fisch M; Soave A; Sauter G; Wurlitzer M; Schlüter H; Minner S
Urol Oncol; 2014 Nov; 32(8):1225-33. PubMed ID: 25131659
[TBL] [Abstract][Full Text] [Related]
2. MALDI imaging on large-scale tissue microarrays identifies molecular features associated with tumour phenotype in oesophageal cancer.
Quaas A; Bahar AS; von Loga K; Seddiqi AS; Singer JM; Omidi M; Kraus O; Kwiatkowski M; Trusch M; Minner S; Burandt E; Stahl P; Wilczak W; Wurlitzer M; Simon R; Sauter G; Marx A; Schlüter H
Histopathology; 2013 Oct; 63(4):455-62. PubMed ID: 23855813
[TBL] [Abstract][Full Text] [Related]
3. MALDI mass spectrometric imaging based identification of clinically relevant signals in prostate cancer using large-scale tissue microarrays.
Steurer S; Borkowski C; Odinga S; Buchholz M; Koop C; Huland H; Becker M; Witt M; Trede D; Omidi M; Kraus O; Bahar AS; Seddiqi AS; Singer JM; Kwiatkowski M; Trusch M; Simon R; Wurlitzer M; Minner S; Schlomm T; Sauter G; Schlüter H
Int J Cancer; 2013 Aug; 133(4):920-8. PubMed ID: 23381989
[TBL] [Abstract][Full Text] [Related]
4. MALDI imaging on tissue microarrays identifies molecular features associated with renal cell cancer phenotype.
Steurer S; Seddiqi AS; Singer JM; Bahar AS; Eichelberg C; Rink M; Dahlem R; Huland H; Sauter G; Simon R; Minner S; Burandt E; Stahl PR; Schlomm T; Wurlitzer M; Schlüter H
Anticancer Res; 2014 May; 34(5):2255-61. PubMed ID: 24778028
[TBL] [Abstract][Full Text] [Related]
5. MALDI imaging mass spectrometry reveals multiple clinically relevant masses in colorectal cancer using large-scale tissue microarrays.
Hinsch A; Buchholz M; Odinga S; Borkowski C; Koop C; Izbicki JR; Wurlitzer M; Krech T; Wilczak W; Steurer S; Jacobsen F; Burandt EC; Stahl P; Simon R; Sauter G; Schlüter H
J Mass Spectrom; 2017 Mar; 52(3):165-173. PubMed ID: 28117928
[TBL] [Abstract][Full Text] [Related]
6. Gene expression profiling of progressive papillary noninvasive carcinomas of the urinary bladder.
Wild PJ; Herr A; Wissmann C; Stoehr R; Rosenthal A; Zaak D; Simon R; Knuechel R; Pilarsky C; Hartmann A
Clin Cancer Res; 2005 Jun; 11(12):4415-29. PubMed ID: 15958626
[TBL] [Abstract][Full Text] [Related]
7. Multicenter matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI MSI) identifies proteomic differences in breast-cancer-associated stroma.
Dekker TJ; Balluff BD; Jones EA; Schöne CD; Schmitt M; Aubele M; Kroep JR; Smit VT; Tollenaar RA; Mesker WE; Walch A; McDonnell LA
J Proteome Res; 2014 Nov; 13(11):4730-8. PubMed ID: 24762205
[TBL] [Abstract][Full Text] [Related]
8. MALDI IMS and Cancer Tissue Microarrays.
Casadonte R; Longuespée R; Kriegsmann J; Kriegsmann M
Adv Cancer Res; 2017; 134():173-200. PubMed ID: 28110650
[TBL] [Abstract][Full Text] [Related]
9. The frequency of hydronephrosis at initial diagnosis and its effect on recurrence and progression in patients with superficial bladder cancer.
Divrik RT; Sahin A; Altok M; Unlü N; Zorlu F
J Urol; 2007 Sep; 178(3 Pt 1):802-6; discussion 806. PubMed ID: 17632171
[TBL] [Abstract][Full Text] [Related]
10. High-throughput tissue microarray analysis of COX2 expression in urinary bladder cancer.
Wild PJ; Kunz-Schughart LA; Stoehr R; Burger M; Blaszyk H; Simon R; Gasser T; Mihatsch M; Sauter G; Hartmann A
Int J Oncol; 2005 Aug; 27(2):385-91. PubMed ID: 16010419
[TBL] [Abstract][Full Text] [Related]
11. Can tissue microarray-based analysis of protein expression predict recurrence of stage Ta bladder cancer?
Gudjónsson S; Bendahl PO; Chebil G; Höglund M; Lindgren D; Lundberg LM; Lövgren K; Fernö M; Månsson W; Liedberg F
Scand J Urol Nephrol; 2011 Sep; 45(4):270-7. PubMed ID: 21504385
[TBL] [Abstract][Full Text] [Related]
12. High level of mature tumor-infiltrating dendritic cells predicts progression to muscle invasion in bladder cancer.
Ayari C; LaRue H; Hovington H; Caron A; Bergeron A; Têtu B; Fradet V; Fradet Y
Hum Pathol; 2013 Aug; 44(8):1630-7. PubMed ID: 23574787
[TBL] [Abstract][Full Text] [Related]
13. Combination of CK20 and Ki-67 immunostaining analysis predicts recurrence, progression, and cancer-specific survival in pT1 urothelial bladder cancer.
Bertz S; Otto W; Denzinger S; Wieland WF; Burger M; Stöhr R; Link S; Hofstädter F; Hartmann A
Eur Urol; 2014 Jan; 65(1):218-26. PubMed ID: 22633802
[TBL] [Abstract][Full Text] [Related]
14. Novel molecular tumour classification using MALDI-mass spectrometry imaging of tissue micro-array.
Djidja MC; Claude E; Snel MF; Francese S; Scriven P; Carolan V; Clench MR
Anal Bioanal Chem; 2010 May; 397(2):587-601. PubMed ID: 20204332
[TBL] [Abstract][Full Text] [Related]
15. Molecular alterations associated with bladder cancer initiation and progression.
Cordon-Cardo C
Scand J Urol Nephrol Suppl; 2008 Sep; (218):154-65. PubMed ID: 18815930
[TBL] [Abstract][Full Text] [Related]
16. MALDI direct analysis and imaging of frozen versus FFPE tissues: what strategy for which sample?
Wisztorski M; Franck J; Salzet M; Fournier I
Methods Mol Biol; 2010; 656():303-22. PubMed ID: 20680599
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of neuron-associated protein expression in non-muscle-invasive urothelial bladder cancer.
Mhawech-Fauceglia P; Ali L; Cheney RT; Groth J; Herrmann FR
J Clin Pathol; 2009 Aug; 62(8):710-4. PubMed ID: 19638542
[TBL] [Abstract][Full Text] [Related]
18. Expression of the endothelin axis in noninvasive and superficially invasive bladder cancer: relation to clinicopathologic and molecular prognostic parameters.
Eltze E; Wild PJ; Wülfing C; Zwarthoff EC; Burger M; Stoehr R; Korsching E; Hartmann A
Eur Urol; 2009 Nov; 56(5):837-45. PubMed ID: 18945538
[TBL] [Abstract][Full Text] [Related]
19. In MALDI-Mass Spectrometry Imaging on Formalin-Fixed Paraffin-Embedded Tissue Specimen Section Thickness Significantly Influences m/z Peak Intensity.
Longuespée R; Kriegsmann K; Cremer M; Zgorzelski C; Casadonte R; Kazdal D; Kriegsmann J; Weichert W; Schwamborn K; Fresnais M; Schirmacher P; Kriegsmann M
Proteomics Clin Appl; 2019 Jan; 13(1):e1800074. PubMed ID: 30216687
[TBL] [Abstract][Full Text] [Related]
20. Association of TSC1/hamartin, 14-3-3sigma, and p27 expression with tumor outcomes in patients with pTa/pT1 urothelial bladder carcinoma.
Mhawech-Fauceglia P; Alvarez V; Fischer G; Beck A; Herrmann FR
Am J Clin Pathol; 2008 Jun; 129(6):918-23. PubMed ID: 18480009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
